Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics.
Read more about cookies
Primary cardioprotection with dexrazoxane in patients with childhood cancer who are expected to receive anthracyclines
dec. 2022
Esmée C., de Baat, et al
The Lancet Child and Adolescent Health
Childhood cancer survivorship care during the COVID-19 pandemic
dec. 2022
, et al
Journal of Cancer Survivorship
Evaluating the feasibility, effectiveness and costs of implementing person-centred follow-up care for childhood cancer survivors in four European countries
nov. 2022
Rebecca J., Van Kalsbeek, et al
BMJ Open
Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines
sep. 2022
Esmée C., de Baat, et al
Cochrane Database of Systematic Reviews
Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors
